- Home
- GOSS vs GHG Comparison
GOSS vs GHG Comparison
Compare GOSS & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- GHG
- Stock Information
- Founded
- GOSS 2015
- GHG 2004
- Country
- GOSS United States
- GHG China
- Employees
- GOSS N/A
- GHG N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- GOSS Health Care
- GHG Consumer Discretionary
- Exchange
- GOSS Nasdaq
- GHG Nasdaq
- Market Cap
- GOSS 230.8M
- GHG 255.9M
- IPO Year
- GOSS 2019
- GHG 2018
- Fundamental
- Price
- GOSS $0.98
- GHG $3.17
- Analyst Decision
- GOSS Strong Buy
- GHG
- Analyst Count
- GOSS 5
- GHG 0
- Target Price
- GOSS $9.20
- GHG N/A
- AVG Volume (30 Days)
- GOSS 939.3K
- GHG 24.4K
- Earning Date
- GOSS 11-07-2024
- GHG 11-25-2024
- Dividend Yield
- GOSS N/A
- GHG 3.19%
- EPS Growth
- GOSS N/A
- GHG 69.37
- EPS
- GOSS N/A
- GHG 0.34
- Revenue
- GOSS $95,842,000.00
- GHG $208,477,725.00
- Revenue This Year
- GOSS N/A
- GHG N/A
- Revenue Next Year
- GOSS N/A
- GHG $8.78
- P/E Ratio
- GOSS N/A
- GHG $9.28
- Revenue Growth
- GOSS N/A
- GHG 48.19
- 52 Week Low
- GOSS $0.45
- GHG $2.31
- 52 Week High
- GOSS $1.60
- GHG $4.57
- Technical
- Relative Strength Index (RSI)
- GOSS 50.68
- GHG 60.58
- Support Level
- GOSS $0.98
- GHG $3.06
- Resistance Level
- GOSS $1.09
- GHG $3.35
- Average True Range (ATR)
- GOSS 0.06
- GHG 0.18
- MACD
- GOSS -0.00
- GHG 0.03
- Stochastic Oscillator
- GOSS 26.14
- GHG 72.04
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.